Ocular Sarcoidosis Open Label Trial of ACTHAR Gel

Cleveland Clinical Foundation
12 Feb, 2019 ,

Treatment with ACTHAR Gel will result in a reduction of ocular inflammation in patients with active ocular sarcoidosis that requires systemic immunosuppressant therapy (hypothesis)

 

Source
OPHTHALMOLOGY

Also Read

Journal of Pediatric Endocrinology and Metabolism
Sep 07, 2019
Biochemical and Clinical Features of Insulinoma in a Patient with Turner Syndrome
Aug 23, 2019
Obstructive Jaundice 14 Years after Cholecystectomy
Aug 23, 2019
Ovarian Mucinous Borderline Tumor in a patient with a Large Solid Component
Aug 23, 2019